Cytokinetics is a specialty cardiovascular biopharmaceutical company focused on developing first-in-class muscle activators and inhibitors for cardiac muscle dysfunction. With over 25 years of scientific innovation, the company is advancing a pipeline of potential new medicines and is preparing to launch its first commercial product.